FDA Commissioner Hamburg to Deliver Keynote at RAPS Conference

ROCKVILLE, Md., June 1 FDA-keynote-RAPS-conf
New FDA Commissioner to Address Regulatory Professionals' Largest Gathering

ROCKVILLE, Md., June 1 /PRNewswire-USNewswire/ -- Dr. Margaret Hamburg, the newly confirmed commissioner of the US Food and Drug Administration (FDA), will address regulatory professionals as the closing keynote speaker at the 2009 Annual Conference of the Regulatory Affairs Professionals Society (RAPS). The 2009 RAPS Annual Conference & Exhibition will take place 13-16 September in Philadelphia. The event is the largest of its kind exclusively for regulatory professionals in the healthcare product sector.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070314/DCW091LOGO)

"At a time when open, efficient communication between FDA and healthcare product developers, manufacturers and marketers is more complex and more important than ever, Dr. Hamburg's eagerness in speaking to regulatory professionals is most welcome," said RAPS Executive Director Sherry Keramidas, PhD, CAE. "The global regulatory professional community has been encouraged by her early comments on FDA's future and we are excited to hear from her in person."

Sworn in as the newest FDA commissioner in May, Dr. Margaret Hamburg is an internationally recognized leader in public health and medicine, and an authority on global health, public health systems, infectious disease, bioterrorism and emergency preparedness. She has vowed to restore public confidence in FDA by making the agency's public health mission its top measure of success, putting science first and increasing accountability.

Dr. Margaret Hamburg previously served as the assistant secretary for planning and evaluation in the US Department of Health and Human Services under President Clinton, and as the assistant director of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. For six years, she served as the commissioner of health for the City of New York. Most recently, she was the Nuclear Threat Initiative's founding vice president for the Biological Program. She is only the second woman to serve as FDA commissioner in the agency's 100-year history.

Members of the working media wishing to cover all or part of the 2009 RAPS Annual Conference & Exhibition should contact RAPS Communications Manager Zachary Brousseau at zbrousseau@raps.org or +1 301 770 2920, ext. 245.

About RAPS The Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the rapidly growing medical device, pharmaceutical and biotechnology sectors. As regulatory professionals, RAPS members perform vital work in all areas of the healthcare product lifecycle, ensuring these products are safe and effective, while driving organizational strategy and sound decision-making. RAPS supports these individuals and the regulatory profession as a whole by providing education and training, certification, professional standards, research, knowledge-sharing, publications, networking and career development opportunities and other valuable resources; and is committed to helping its members continually develop the knowledge and skills they need to excel. RAPS.org




SOURCE Regulatory Affairs Professionals Society (RAPS)